verified SJR 1,119 · Q1 • database Scopus / SJR & Web of Science indexed

United States · W.B. Saunders

workspace_premium Q1 — Rheumatology lock_open Open Access

Rheumatic Disease Clinics of North America

Rheumatic Disease Clinics of North America is a journal indexed in SJR in Rheumatology with an H index of 103. It has an SJR impact factor of 1,119 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,119.

ISSN: 0889-857X

Publisher: W.B. Saunders

Category: Rheumatology

Indexation: verifiedScopus / SJR verifiedWeb of Science

open_in_new Portal NPD menu_book Guidelines NPD

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

1,119 Q1

H-index 103

Acceptance rate pie_chart

25% Selective

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

NPD Open Access

Non-OA path 0 €

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

1,119

H-index

103

Docs (year)

Docs 3y

194

Total refs

3030

Cites 3y

620

Citable 3y

158

Cites/Doc 2y

2.74

Ref/Doc

50.5

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

0 €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

ARE ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES PATHOGENIC?

Vitamin D: Metabolism

Cytokines in the rheumatic diseases

CYCLOSPORINE, FK-506, RAPAMYCIN, AND OTHER IMMUNOMODULATORS

CLINICAL USE OF SEROLOGICAL TESTS FOR ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES

CLINICAL PROBLEMS

Clinical experience with inhibition of interleukin-6

CARDIAC INVOLVEMENT IN SCLERODERMA

Bone metabolism in childhood rheumatic disease

B lymphocyte depletion therapy with rituximab in rheumatoid arthritis

Autonomic Dysfunction in Rheumatic Diseases

AUTOIMMUNE COAGULATION DISORDERS

SHOW MORE ARTICLES

ARE ANTINEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIDES PAUCI-IMMUNE?

Acute and Chronic Tubulointerstitial Nephritis of Rheumatic Causes

Applications of polymerase chain reaction in rheumatology

Apoptosis in rheumatoid arthritis: friend or foe

Apoptosis in glomerulonephritis

Apoptosis and systemic lupus erythematosus

ANTIPHOSPHOLIPID SYNDROME IN PREGNANCY

ANTIPHOSPHOLIPID ANTIBODIES IN HEALTHY PREGNANT WOMEN

Animal models of myositis

ANIMAL MODELS FOR ANTIPHOSPHOLIPID SYNDROME IN PREGNANCY

Advances in the Assessment of Fibromyalgia

ADULT IMMUNODEFICIENCY AND RHEUMATIC DISEASE

FAQs

Rheumatic Disease Clinics of North America has an SJR of 1,119 (best quartile Q1) in the CountryOfPapers database.

Immediate OA APC is not available (NPD). Non-OA / submission fee is 0 EUR.

The acceptance rate recorded for Rheumatic Disease Clinics of North America is 25%.

Rheumatic Disease Clinics of North America

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of Rheumatic Disease Clinics of North America?

What is the APC / publication cost?

What is the acceptance rate?